142 related articles for article (PubMed ID: 15501963)
1. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage.
David O; Jett J; LeBeau H; Dy G; Hughes J; Friedman M; Brody AR
Clin Cancer Res; 2004 Oct; 10(20):6865-71. PubMed ID: 15501963
[TBL] [Abstract][Full Text] [Related]
2. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.
Erman M; Grunenwald D; Penault-Llorca F; Grenier J; Besse B; Validire P; Morat L; Girard P; Le Chevalier T; Sabatier L; Soria JC
Lung Cancer; 2005 Mar; 47(3):315-23. PubMed ID: 15713515
[TBL] [Abstract][Full Text] [Related]
5. Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxia-inducible factor-1alpha in non-small cell lung cancers.
Hirami Y; Aoe M; Tsukuda K; Hara F; Otani Y; Koshimune R; Hanabata T; Nagahiro I; Sano Y; Date H; Shimizu N
Cancer Lett; 2004 Oct; 214(2):157-64. PubMed ID: 15363541
[TBL] [Abstract][Full Text] [Related]
6. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
7. PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer.
Lim WT; Zhang WH; Miller CR; Watters JW; Gao F; Viswanathan A; Govindan R; McLeod HL
Oncol Rep; 2007 Apr; 17(4):853-7. PubMed ID: 17342327
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
10. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
11. Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC.
Mukohara T; Kudoh S; Matsuura K; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Inoue K; Wanibuchi H; Fukushima S; Yoshikawa J
Anticancer Res; 2004; 24(1):11-7. PubMed ID: 15015570
[TBL] [Abstract][Full Text] [Related]
12. Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.
Watzka SB; Setinek U; Stubenberger EB; Tötsch M; Dekan G; Marcher M; Fleck T; Müller MR
Eur J Cardiothorac Surg; 2011 Feb; 39(2):180-4. PubMed ID: 20580243
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.
Blackhall FH; Pintilie M; Michael M; Leighl N; Feld R; Tsao MS; Shepherd FA
Clin Cancer Res; 2003 Jun; 9(6):2241-7. PubMed ID: 12796392
[TBL] [Abstract][Full Text] [Related]
14. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
16. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR
Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Hasegawa S; Otake Y; Morioka Y; Takahashi C; Noda M; Ito H; Wada H; Tanaka F
Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]